ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XNCR vs ABBV // EV/EBITDA & P/E VALUATION

Xencor Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: XNCR 2 — ABBV 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XNCR VS. ABBV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XNCR ABBV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 70.20% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -21.30% 29.00% -50.30 ABBV /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 33.3x — TIE /valuation <GO>
Free Cash Flow Yield -6.37% 3.47% -9.84 ABBV /fcf-yield <GO>
Operating Margin -60.00% 24.60% -84.60 ABBV /operating-margins <GO>
Net Profit Margin -60.00% 6.90% -66.90 ABBV /net-margins <GO>
Revenue Growth (YoY) 13.70% 8.60% +5.10 XNCR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.27% -2.27 ABBV /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.32 5.33 -1.01 ABBV /balance-sheet <GO>
Piotroski F-Score Quality 4/9 7/9 -3.00 ABBV /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 68.0 65.1 +2.87 XNCR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.15 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 113.1x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.17B $513.86B -$511.69B ABBV /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XNCR REV ABBV REV XNCR GROSS % ABBV GROSS % XNCR FCF ABBV FCF
FY 2025 $125.6M $61.16B — 70.2% -$138.3M $17.82B
FY 2024 $110.5M $56.33B — 70.0% -$208.3M $17.83B
FY 2023 $174.6M $54.32B — — -$77.9M $20.39B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XNCR // BETA —
ABBV // BETA 1.15